808 related articles for article (PubMed ID: 25282191)
1. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
[TBL] [Abstract][Full Text] [Related]
3. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
6. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
[TBL] [Abstract][Full Text] [Related]
7. Postprandial changes in gut regulatory peptides in gastric bypass patients.
Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
[TBL] [Abstract][Full Text] [Related]
9. The post-prandial pattern of gut hormones is related to magnitude of weight-loss following gastric bypass surgery: a case-control study.
Gerner T; Johansen OE; Olufsen M; Torjesen PA; Tveit A
Scand J Clin Lab Invest; 2014 Apr; 74(3):213-8. PubMed ID: 24472033
[TBL] [Abstract][Full Text] [Related]
10. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
[TBL] [Abstract][Full Text] [Related]
11. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
[TBL] [Abstract][Full Text] [Related]
12. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
[TBL] [Abstract][Full Text] [Related]
13. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy.
Papamargaritis D; le Roux CW; Sioka E; Koukoulis G; Tzovaras G; Zacharoulis D
Surg Obes Relat Dis; 2013; 9(2):192-201. PubMed ID: 23183113
[TBL] [Abstract][Full Text] [Related]
14. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
[TBL] [Abstract][Full Text] [Related]
15. Fasting and post-prandial peptide YY levels in obese patients before and after mini versus Roux-en-Y gastric bypass.
Dardzińska JA; Kaska Ł; Wiśniewski P; Aleksandrowicz-Wrona E; Małgorzewicz S
Minerva Chir; 2017 Feb; 72(1):24-30. PubMed ID: 27787482
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
17. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
[TBL] [Abstract][Full Text] [Related]
18. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
Werling M; Vincent RP; Cross GF; Marschall HU; Fändriks L; Lönroth H; Taylor DR; Alaghband-Zadeh J; Olbers T; Le Roux CW
Scand J Gastroenterol; 2013 Nov; 48(11):1257-64. PubMed ID: 24044585
[TBL] [Abstract][Full Text] [Related]
19. Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes.
Yan W; Polidori D; Yieh L; Di J; Wu X; Moreno V; Li L; Briscoe CP; Shankley N; Dohm GL; Pories WJ
Obes Surg; 2014 Nov; 24(11):1969-74. PubMed ID: 24972682
[TBL] [Abstract][Full Text] [Related]
20. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
